Yahoo Web Search

Search results

  1. Mar 14, 2022 · The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines.

  2. Jun 8, 2023 · Research. Vaccines. Cross-posted from: NIH Director’s Blog. Posted on June 6th, 2023 by Lawrence Tabak, D.D.S., Ph.D. Researchers used a customized nanoparticle (top left) to learn more about guiding the immune system to mount a desired robust response, the type needed for an effective HIV vaccine. Credit: Donny Bliss, NIH.

  3. Feb 3, 2021 · February 03, 2021. NEW YORK and LA JOLLA, CA— A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.

  1. People also search for